Chong Kun Dang Holdings Corp. (KRX:001630)
51,700
+100 (0.19%)
Last updated: Jun 27, 2025
Chong Kun Dang Holdings Revenue
Chong Kun Dang Holdings had revenue of 246.62B KRW in the quarter ending March 31, 2025, a decrease of -1.35%. This brings the company's revenue in the last twelve months to 954.38B, up 4.28% year-over-year. In the year 2024, Chong Kun Dang Holdings had annual revenue of 957.75B with 8.86% growth.
Revenue (ttm)
954.38B
Revenue Growth
+4.28%
P/S Ratio
0.25
Revenue / Employee
25.79B
Employees
37
Market Cap
241.36B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 957.75B | 77.97B | 8.86% |
Dec 31, 2023 | 879.78B | -29.18B | -3.21% |
Dec 31, 2022 | 908.96B | -17.01B | -1.84% |
Dec 31, 2021 | 925.98B | 67.86B | 7.91% |
Dec 31, 2020 | 858.12B | 137.47B | 19.08% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Samsung Biologics | 4,898.69B |
Celltrion | 3,662.23B |
ALTEOGEN | 151.65B |
Yuhan | 2,114.76B |
SK Biopharmaceuticals | 578.00B |
HLB Co., Ltd. | 74.64B |
PharmaResearch | 392.31B |
Peptron | 4.30B |